In order to predict the impact of FDX1 expression on chemotherapy, we utilized the pRRophetic algorithm to evaluate the response to chemotherapy based on the half-maximal inhibitory concentration (IC50) for patients with glioblastoma multiforme (GBM) in the GDSC database. The gene discussed is FDX1; the disease is glioblastoma.